Tower Research Capital LLC (Trc) Incyte Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Incyte Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,070 shares of INCY stock, worth $289,173. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,070
Previous 77,377
94.74%
Holding current value
$289,173
Previous $4.69 Million
94.26%
% of portfolio
0.01%
Previous 0.08%
Shares
28 transactions
Others Institutions Holding INCY
# of Institutions
642Shares Held
186MCall Options Held
714KPut Options Held
557K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.18 Billion21.76% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.52 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.45 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.09 Billion0.61% of portfolio
-
State Street Corp Boston, MA10.6MShares$750 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15.8B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...